Phosphorylation and proteasome-dependent degradation of Bcl-2 in mitotic-arrested cells after microtubule damage

Biochemical and Biophysical Research Communications

Volumn 262, Issue 3, 1999, Pages 823-827

  Chadebech, Philippe ^a   Brichese, Laetitia ^a   Baldin, Véronique ^a   Vidal, Simone ^a   Valette, Annie ^a  

^a UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 AMINOPURINE; CASPASE INHIBITOR; LACTACYSTIN; PACLITAXEL; PROTEASOME; PROTEASOME INHIBITOR; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DAMAGE; DOWN REGULATION; HUMAN; HUMAN CELL; MICROTUBULE; MITOSIS INHIBITION; MITOSIS SPINDLE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING;

EID: 0033533499     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1999.1291     Document Type: Article

References (24)

1. Schiff P. B., Horwitz S. B. Proc. Natl. Acad. Sci. USA. 77:1980;1561-1565.
2. Rowinsky E. K., Donehower R. C., Jones R. J., Tucker R. W. Cancer Res. 48:1988;4093-4100.
3. Tang C., Willingham M. C., Reed J. C., Miyashita T., Ray S., Ponnathpur V., Huang Y., Mahoney M. E., Bullock G., Bhalla K. Leukemia. 8:1994;1960-1969.
4. Haldar S., Jena N., Croce C. M. Proc. Natl. Acad. Sci. USA. 92:1995;4507-4511.
5. Haldar S., Chintapalli J., Croce C. M. Cancer Res. 56:1996;1253-1255.
6. Blagosklonny M. V., Schulte T., Nguyen P., Trepel J., Neckers L. M. Cancer Res. 56:1996;1851-1854.
7. Blagosklonny M. V., Giannakakou P., el-Deiry W. S., Kingston D. G., Higgs P. I., Neckers L., Fojo T. Cancer Res. 57:1997;130-135.
8. Haldar S., Basu A., Croce C. M. Cancer Res. 58:1998;1609-1615.
9. Srivastava R. K., Srivastava A. R., Korsmeyer S. J., Nesterova M., Cho-Chung Y. S., Longo D. L. Mol. Cell. Biol. 18:1998;3509-3517.
10. Ling Y. H., Tornos C., Perez-Soler R. J. Biol. Chem. 273:1998;18984-18991.
11. Scatena C. D., Stewart Z. A., Mays D., Tang L. J., Keefer C. J., Leach S. D., Pietenpol J. A. J. Biol. Chem. 273:1998;30777-30784.
12. Barboule N., Chadebech P., Baldin V., Vidal S., Valette A. Oncogene. 15:1997;2867-2875.
13. Lafon C., Guerrin M., Barboule N., Mathieu C., Royer I., Monsarrat B., Wright M., Valette A. Anti-Cancer Drugs. 7:1996;67-74.
14. Bhalla K., Ibrado A. M., Tourkina E., Tang C., Mahoney M. E., Huang Y. Leukemia. 7:1993;563-568.
15. Ibrado A. M., Huang Y., Fang G., Bhalla K. Cell Growth Differ. 7:1996;1087-1094.
16. Panvichian R., Orth K., Day M. L., Day K. C., Pilat M. J., Pienta K. J. Cancer Res. 58:1998;4667-4672.
17. Grandgirard D., Studer E., Monney L., Belser T., Fellay I., Borner C., Michel M. R. EMBO J. 17:1998;1268-1278.
18. Cheng E. H., Kirsch D. G., Clem R. J., Ravi R., Kastan M. B., Bedi A., Ueno K., Hardwick J. M. Science. 278:1997;1966-1968.
19. Andreassen P. R., Margolis R. L. Proc. Natl. Acad. Sci. USA. 89:1992;2272-2276.
20. Andreassen P. R., Margolis R. L. J. Cell. Biol. 127:1994;789-802.
21. Goldberg A. L., Rock K. L. Nature. 357:1992;375-379.
22. Dimmeler S., Breitschopf K., Haendeler J., Zeiher A. M. J. Exp. Med. 189:1999;1815-1822.
23. Vlach J., Hennecke S., Amati B. EMBO J. 16:1997;5334-5344.
24. Baldin V., Cans C., Knibiehler M., Ducommun B. J. Biol. Chem. 272:1997;32731-32734.